TG Therapeutics, Inc. (TGTX) key performance indicators and operating metrics (3 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Total Net Product Revenue | 201.31M | FY2026-Q1 |
| Briumvi U.S. Net Product Revenue | 194.8M | FY2026-Q1 |
| License, Milestone, Royalty, and Other Revenue | 3.61M | FY2026-Q1 |
Back to TGTX overview · TGTX earnings · TGTX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.